Durvalumab in Pediatric and Adolescent Patients

Clinical trial NCT02793466 · COMPLETED

Trial details

NCT number: NCT02793466
Sponsor: Leo Mascarenhas
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Lymphoma Central Nervous System Tumors

Start date: 2016-07-01
Primary completion: 2022-11-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.